SONATA THERAPEUTICS
DEAD

Serial Number

97420640

Owner

Sonata Therapeutics, Inc.

Attorney

Christina M. Licursi

Filing Date

May 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SONATA THERAPEUTICS Trademark

Serial Number: 97420640

SONATA THERAPEUTICS is a trademark filed by Sonata Therapeutics, Inc. on May 20, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Sonata Therapeutics, Inc. (12 trademarks)

99 Coolidge Ave, Suite 500
Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

May 20, 2022

Registration Date

Not Registered

Goods & Services

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Pharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 1, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 1, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 19, 2024 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 2, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 2, 2024 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 29, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2023 CNRT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 25, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 25, 2023 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 25, 2023 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2022 NWOS